Display Settings:

Format

Send to:

Choose Destination
Curr Hypertens Rep. 2003 Oct;5(5):368-71.

Regression of left ventricular hypertrophy: are there preferred drugs?

Author information

  • 1Department of Medicine, Division of Cardiology, Long Island Jewish Medical Center, 270-05 76th Avenue, New Hyde Park, NY 11040, USA. jdiamond@lij.edu

Abstract

The presence of left ventricular hypertrophy (LVH) confers markedly increased risk of cardiovascular morbidity and mortality in patients with hypertension. Regression of left ventricular (LV) mass with antihypertensive therapy is associated with reduction in cardiovascular events. In studies based on monotherapy, among the classes of antihypertensive drugs that have been adequately tested, diuretics and angiotensin-converting enzyme inhibitors appear to be the most effective agents for reducing LV mass. New avenues of research, based on combination antihypertensive therapy and on a more sophisticated understanding of the molecular mechanisms of LVH, may yield new pharmacologic approaches to regressing LV mass.

PMID:
12948428
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk